Using Diagnostic Tools to Stage Breast Cancer
This trial is active, not recruiting.
|Treatment||mri, digital mammography, ultrasound and positron emission tomography (pet)|
|Sponsor||University of Pennsylvania|
|Start date||March 2002|
|End date||July 2007|
|Trial size||400 participants|
|Trial identifier||NCT00367666, NIH funded, Protocol 414500|
This project is aimed at investigating the relative diagnostic and synergy of four state of the art breast imaging techniques (magnetic resonance imaging (MRI), full-field digital mammography (DMAM), ultrasound, and positron emission tomography (PET)) with respect to determining the extent of breast cancer.
|Intervention model||single group assignment|
Female participants from 18 years up to 80 years old.
Inclusion Criteria: - Women recently diagnosed with Breast Cancer - Will be undergoing surgery (after study) at the Hospital of the University of Pennsylvania Exclusion Criteria: - Contraindications to MRI - previously diagnosed with breast cancer (in the smae breast) within the past 5 years - Patients with known locally advanced cancer (prior to study entry) being treated with preoperative adjuvant therapy. - Pregnant women
|Official title||Evaluation of Multimodality Breast Imaging: Lesion Staging|
|Principal investigator||Abass Alavi, MD|
Call for more information